Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MMF for Refractory IgA Nephropathy in Bangladesh
NCT07785128Phase 2Not yet recruiting
- Sponsor
- Shaheed Suhrawardy Medical College and Hospital
- Start
- Sep 2026
- Primary completion
- May 2027
- Countries
- 1
01
Overview
A Phase 2 trial of mycophenolate mofetil in IgA nephropathy (IgAN), sponsored by Shaheed Suhrawardy Medical College and Hospital. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
mycophenolate mofetil
03
Conditions
IgA nephropathy (IgAN)
Beyond the preview
Go deeper on NCT07785128.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07785128.